---
topic_name: Psychopharmacology – Other Psychoactive Drugs
domain: 1: Biological Bases
slug: psychopharmacology-other-psychoactive-drugs
generated_at: 2025-11-15T19:56:13.974Z
model: claude-sonnet-4-5-20250929
version: 1
---

## Why These "Other" Drugs Matter More Than You Think

When you're cramming for the EPPP, it's easy to focus on antidepressants and antipsychotics—they get the spotlight in most clinical settings. But here's the reality: A huge portion of your future clients will be taking benzodiazepines for anxiety, or they'll ask you about their beta-blocker's effect on their panic attacks, or you'll need to coordinate care with a physician prescribing ADHD medications. These "other" psychoactive drugs are everywhere in clinical practice, and the EPPP knows it.

Think of this section as your clinical Swiss Army knife. You won't always need every tool, but when you do need to know whether a client's confusion might be from lithium toxicity or why their smoking cessation plan includes an antidepressant, you'll be glad you paid attention.

## The Quick-Relief vs. Long-Term Solution: Sedatives, Hypnotics, and Anxiolytics

### Benzodiazepines: The Fast Food of Anxiety Treatment

Benzodiazepines—drugs like Valium, Xanax, and Ativan—work by boosting GABA, your brain's natural "calm down" signal. They're like hitting the emergency brake on your nervous system. This makes them incredibly useful for immediate relief, but just like fast food, they're not a great long-term solution.

Here's the clinical decision-making you need to understand: When a client is having a panic attack or severe acute anxiety, benzodiazepines work fast—sometimes within 30 minutes. But when you're treating generalized anxiety disorder that's been going on for months, SSRIs or SNRIs are usually the better choice, even though they take 4-6 weeks to kick in.

**The Trade-Off Table:**

| Factor | Benzodiazepines | SSRIs/SNRIs |
|--------|----------------|-------------|
| **Speed** | Fast-acting (minutes to hours) | Delayed (4-6 weeks) |
| **Best For** | Acute anxiety, immediate relief | Chronic anxiety, long-term management |
| **Impact on Physical Symptoms** | Strong (rapid heartbeat, sweating) | Weaker |
| **Impact on Worry/Rumination** | Weaker | Strong |
| **Dependence Risk** | High with long-term use | Low |
| **Tolerance Development** | Yes | No |

Side effects? Think of how you feel after taking too much cold medicine: drowsy, unsteady, foggy-headed. Benzodiazepines can also mess with memory and concentration—not great when you're trying to perform at work or remember important conversations.

Here's a crucial exam point: In children and older adults, benzodiazepines can have a **paradoxical effect**—instead of calming someone down, they become agitated and anxious. It's like how overtired toddlers get hyperactive instead of sleepy, except it's a pharmacological reaction, not just behavior.

**The Danger Zone:** Mixing benzodiazepines with alcohol creates a synergistic effect—not just additive (1+1=2), but multiplicative (1+1=5). Both substances depress the central nervous system, and together they can be lethal. Also watch out for interactions with blood pressure medications, which can cause dangerous drops in blood pressure.

When someone's been taking benzodiazepines long-term and wants to stop, you can't just quit cold turkey. Withdrawal can cause seizures, delirium, and severe rebound anxiety. The tapering schedule depends on the drug's half-life: shorter half-life drugs like Xanax and Ativan need longer, more gradual tapers.

### Barbiturates: The Old Guard

Barbiturates (Pentothal, Amytal, Seconal) are like benzodiazepines' older, more dangerous cousins. They also enhance GABA activity but are rarely prescribed anymore because they're riskier. They're mainly used as anesthetics or for seizure control. Side effects are similar to benzodiazepines—drowsiness, confusion, cognitive impairment—but the risks are higher. Like benzodiazepines, mixing them with alcohol can be fatal.

### Buspirone: The Patient Player

Buspirone (BuSpar) is the outlier in this group. It treats generalized anxiety disorder without causing sedation, dependence, or tolerance. Think of it as the reliable hybrid car compared to benzodiazepines' sports car—it won't give you that instant rush of relief, but it's safer for the long haul. Side effects are mild: dizziness, dry mouth, nausea, headache.

## Opioids: Understanding the Crisis

The narcotic-analgesics—everything from prescription painkillers like oxycodone to illegal heroin—mimic your body's natural pain relievers (endorphins and enkephalins). They're incredibly effective for pain management, which is why they're also incredibly addictive.

Here's what you need to know for clinical work: Methadone is used for heroin detoxification because it satisfies the brain's craving without producing the euphoric high. It's like switching from regular coffee to decaf—you avoid the withdrawal headache, but you don't get the buzz.

Side effects include constipation (this is consistent and can be severe), drowsiness, constricted pupils, and respiratory depression. Overdose is the leading cause of accidental death in the U.S., with opioids being the primary culprit.

Withdrawal from opioids feels like a terrible flu at first: runny nose, watery eyes, muscle aches, fever. Then it intensifies with insomnia, vomiting, diarrhea, and elevated blood pressure. Unlike alcohol or benzodiazepine withdrawal, opioid withdrawal is extremely uncomfortable but typically not life-threatening.

## Beta-Blockers: Stage Fright's Nemesis

Beta-blockers like propranolol (Inderal) were originally designed for heart conditions—they calm down your sympathetic nervous system. But here's an interesting clinical application: they're excellent for performance anxiety.

Imagine you're a musician with a big audition. Your hands are shaking, heart racing, sweating—but mentally, you know your music cold. This is where propranolol shines. It blocks the physical symptoms of anxiety (the racing heart, trembling hands) without affecting your cognitive function. It doesn't help much with the psychological symptoms like worry or dread, just the body's physical response.

Common side effects include low blood pressure, decreased sex drive, insomnia, and depression. Important exam point: You can't stop beta-blockers abruptly—doing so can cause rebound hypertension (dangerously high blood pressure), tremors, and cardiac problems.

## Mood Stabilizers: Leveling the Bipolar Rollercoaster

### Lithium: The Gold Standard with a Narrow Window

Lithium has been treating bipolar disorder since the 1940s and remains the first-line treatment for classic bipolar disorder with euphoric mania. It's highly effective, but it requires constant monitoring because the therapeutic dose is dangerously close to the toxic dose—what we call a narrow therapeutic window.

Common side effects include a metallic taste (clients often describe this first), increased thirst, weight gain, hand tremor, and cognitive dulling. The serious concern is lithium toxicity, which can cause seizures, coma, and death. This is why blood levels must be checked regularly—it's not optional.

### Anticonvulsant Drugs: The Alternative Route

Carbamazepine (Tegretol) and valproic acid (Depakene) were originally developed for seizures but work well for bipolar disorder, especially with mixed episodes (when depression and mania occur simultaneously) or rapid cycling. Side effects include nausea, dizziness, coordination problems, and cognitive impairment.

The monitoring here is crucial: valproic acid can cause liver failure, and carbamazepine can cause agranulocytosis (dangerously low white blood cell count) or aplastic anemia. Regular blood tests aren't just good practice—they're life-saving.

## Alzheimer's Disease: Buying Time

The drugs for Alzheimer's don't cure or reverse the disease—they slow its progression. Think of them as applying the brakes on a car that's slowly rolling downhill, not stopping it completely, just slowing it down.

**Cholinesterase inhibitors** (Aricept, Exelon, Razadyne) work by preventing the breakdown of acetylcholine, a neurotransmitter that's depleted in Alzheimer's. They're approved for mild to moderate Alzheimer's, with donepezil also approved for severe cases.

**Memantine (Namenda)**, an NMDA receptor antagonist, regulates glutamate activity and is used for moderate to severe Alzheimer's. It works through a different mechanism, so it's sometimes combined with cholinesterase inhibitors.

## ADHD Medications: More Than Just "Study Drugs"

### Psychostimulants: The First Line

Medications like Ritalin, Concerta, and Adderall increase dopamine and norepinephrine in the prefrontal cortex, improving attention and reducing hyperactivity. Here's the paradoxical part that confuses people: stimulants calm down hyperactive kids. Why? Because the hyperactivity often stems from an underactive prefrontal cortex. By stimulating that area, the brain can finally engage its natural braking system.

Common side effects include insomnia, decreased appetite, weight loss, and abdominal pain. In children, these drugs can suppress growth, but "drug holidays" during school breaks can reverse this.

**Important clinical note:** While these drugs help with attention and impulsivity, their impact on actual academic achievement when used alone is unclear. They're tools, not magic bullets. Also, college students often misuse these drugs thinking they'll boost performance, but research shows they mainly increase attention and mood—they don't improve reading comprehension and may actually hurt working memory.

### Second-Line Options: When Stimulants Don't Work

**Atomoxetine (Strattera)** is a norepinephrine reuptake inhibitor and the most common nonstimulant for ADHD. It's particularly useful when patients have comorbid conditions like tic disorders, anxiety, or depression, or when there's a risk of stimulant misuse.

**Guanfacine (Intuniv) and clonidine (Kapvay)** are alpha-2-adrenergic agonists originally developed for high blood pressure. They're typically reserved for patients who also have Tourette's or other tic disorders.

**Third-line options** include tricyclic antidepressants like desipramine and the NDRI bupropion (Wellbutrin), both of which work by increasing dopamine and norepinephrine—similar to stimulants but through different mechanisms.

## Substance Use Disorder Treatments: Supporting Recovery

### Alcohol Use Disorder

**Disulfiram (Antabuse)** creates immediate negative consequences for drinking—nausea, vomiting, rapid heartbeat, headache. It's like installing a punishment app on your phone that gives you an electric shock every time you open social media. Effective, but requires commitment.

**Naltrexone (ReVia)** reduces both the pleasurable effects of and craving for alcohol. **Acamprosate (Campral)** just reduces craving. **Topiramate (Topamax)**, an anti-seizure medication used off-label, works similarly to naltrexone.

### Tobacco Use Disorder

**Nicotine replacement therapy (NRT)** provides a stable, low level of nicotine to prevent withdrawal symptoms—the theory being that it's easier to quit when you're not constantly battling cravings.

**Bupropion** (yes, the same antidepressant used for ADHD) reduces nicotine craving and withdrawal symptoms. **Varenicline** reduces both craving and the rewarding effects of smoking—making cigarettes less satisfying even if you do smoke.

### Cocaine Use Disorder

This is the frustrating one: no FDA-approved medications exist, and research hasn't found strong support for anything. However, some evidence suggests bupropion, topiramate, and certain psychostimulants (modafinil, dextroamphetamine) may help increase abstinence.

## Emerging Treatments: THC and Psychedelics

**THC (Syndros)**, the main psychoactive component of cannabis, has FDA approval for treating anorexia in AIDS patients and chemotherapy-induced nausea in cancer patients. It works by stimulating dopamine release in the brain's reward pathway.

**Psychedelic drugs** like LSD and psilocybin have received FDA "breakthrough therapy" designations (not full approval, but accelerated review status) for treating generalized anxiety disorder and treatment-resistant depression, respectively. Both are serotonin agonists, though LSD also affects dopamine and psilocybin affects glutamate.

## Critical Pharmacology Concepts You Must Know

### Drug Half-Life: Timing Is Everything

A drug's half-life is how long it takes for blood levels to drop to 50% of their peak. This determines dosing schedules: short half-life means frequent doses; long half-life means less frequent doses.

Here's the clinical twist: many drugs have much longer half-lives in older adults due to age-related changes in metabolism. A benzodiazepine that clears a younger person's system in 24 hours might take over 72 hours in an older adult. This is why the prescribing rule for older adults is "start low and go slow"—begin with low doses and increase gradually.

### Tolerance and Cross-Tolerance: The Adaptation Problem

**Tolerance** develops when your body adapts to a drug, requiring higher doses to achieve the same effect. It's like how your eyes adjust to a dark room—what seemed pitch black gradually becomes visible.

**Cross-tolerance** occurs when tolerance to one drug creates tolerance to similar drugs. If someone develops tolerance to alcohol (a CNS depressant), they'll also have tolerance to benzodiazepines and barbiturates (also CNS depressants). This matters for anesthesia, emergency treatment, and understanding addiction patterns.

### Therapeutic Index: The Safety Margin

The therapeutic index (TI) measures how safe a drug is. In animal studies, it's calculated as LD50/ED50 (lethal dose / effective dose). In human studies, it's TD50/ED50 (toxic dose / effective dose).

**Understanding the numbers:**

| Therapeutic Index | Safety Level | Meaning |
|-------------------|--------------|---------|
| **TI = 1.0 or less** | Narrow therapeutic window | DANGEROUS: Effective dose is same or higher than toxic/lethal dose |
| **TI > 1.0** | Wide therapeutic window | SAFER: Effective dose is lower than toxic/lethal dose |

Drugs with narrow therapeutic windows (like lithium) require close monitoring because there's little margin for error. Drugs with wide therapeutic windows are preferred because they're safer—you have more room before reaching dangerous doses.

## Common Misconceptions to Avoid

**Misconception 1:** "Benzodiazepines and SSRIs treat the same symptoms the same way."
- **Reality:** Benzodiazepines primarily target physical anxiety symptoms quickly; SSRIs target cognitive symptoms (worry, rumination) slowly. They're used for different situations.

**Misconception 2:** "Stimulants help everyone focus better."
- **Reality:** Stimulants may improve attention in people without ADHD, but they don't improve comprehension or overall academic performance and may hurt working memory.

**Misconception 3:** "Drug half-life is the same for everyone."
- **Reality:** Half-life varies significantly by age, particularly in older adults, requiring dose adjustments.

**Misconception 4:** "Higher therapeutic index means more effective drug."
- **Reality:** Higher TI means safer drug, not more effective. Effectiveness is measured separately.

## Practice Tips for Remembering

**For drug classes:** Create a mental filing system based on mechanism. GABAergic drugs (benzodiazepines, barbiturates) calm things down. Stimulants (ADHD meds) speed things up. Mood stabilizers level things out.

**For benzodiazepine vs. SSRI decision-making:** Remember "Fast Food vs. Home Cooking." Benzodiazepines are fast but not ideal long-term; SSRIs take time to prepare but are better for sustained nutrition.

**For narrow vs. wide therapeutic window:** Think of it as "room for error." Lithium has almost no room for error (narrow), while benzodiazepines have more room (wider, though still require monitoring).

**For cross-tolerance:** Remember "same family, same adaptation." If drugs work similarly (all CNS depressants), tolerance transfers.

**For withdrawal dangers:** The "Goldilocks rule" - withdrawal from CNS depressants (alcohol, benzodiazepines, barbiturates) can be life-threatening. Withdrawal from opioids feels terrible but typically isn't fatal. Withdrawal from stimulants causes depression and fatigue but isn't medically dangerous.

## Key Takeaways

- **Benzodiazepines** provide fast relief for acute anxiety but risk dependence and tolerance with long-term use; they're dangerous when combined with alcohol
- **SSRIs/SNRIs vs. benzodiazepines**: Choose based on acute vs. chronic needs and whether physical or cognitive symptoms dominate
- **Beta-blockers** effectively treat physical anxiety symptoms (trembling, rapid heartbeat) but don't address psychological worry
- **Lithium** remains first-line for classic bipolar disorder but requires careful monitoring due to narrow therapeutic window
- **ADHD stimulants** improve attention and reduce hyperactivity through increasing prefrontal cortex dopamine and norepinephrine
- **Atomoxetine** is the preferred nonstimulant ADHD medication, especially with comorbid anxiety or tic disorders
- **Opioid overdose** is the leading cause of accidental death in the U.S.; methadone reduces heroin cravings without producing euphoria
- **Alzheimer's medications** (cholinesterase inhibitors and memantine) slow progression but don't cure or reverse the disease
- **Drug half-life** is significantly longer in older adults, requiring the "start low and go slow" approach
- **Therapeutic index** measures safety, not effectiveness; narrow TI drugs (like lithium) require close monitoring
- **Cross-tolerance** occurs between drugs in the same class (e.g., alcohol, benzodiazepines, and barbiturates)
- **Abrupt discontinuation** of benzodiazepines, barbiturates, or beta-blockers can cause severe, potentially life-threatening withdrawal

Remember: These drugs aren't just exam content—they're tools you'll encounter constantly in clinical practice. Understanding their mechanisms, side effects, and interactions will make you a better collaborator with prescribing physicians and a safer practitioner for your clients.